Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing By Watertime - October 20, 2026 2 Post Content RELATED ARTICLESMORE FROM AUTHOR Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA The Problems We Will Be Lucky to Have Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
